1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. Ontario >
  6. Organigram Acquires Motif Labs

M&A Deal Summary

Organigram Acquires Motif Labs

On December 6, 2024, Organigram acquired consumer products company Motif Labs for 90M USD

Acquisition Highlights
  • This is Organigram’s 3rd transaction in the Consumer Products sector.
  • This is Organigram’s largest (disclosed) transaction.
  • This is Organigram’s 3rd transaction in Canada.
  • This is Organigram’s 1st transaction in Ontario.

M&A Deal Summary
Date 2024-12-06
Target Motif Labs
Sector Consumer Products
Buyer(s) Organigram
Deal Type Add-on Acquisition
Deal Value 90M USD
Advisor(s) Jefferies (Financial)
Davies Ward Phillips & Vineberg (Legal)

Target

Motif Labs

Aylmer, Ontario, Canada
Motif Labs is a brand house shaping Canada's cannabis 2.0 market with a portfolio of iconic brands, including BOXHOT (cannabis vape brand), DEBUNK (liquid diamonds vape brand), Rizzlers, and Floe State. Motif Labs was founded in 2017 and is based in Aylmer, Ontario.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Organigram

Toronto, Ontario, Canada
Category Company
Founded 2010
Sector Consumer Products
Employees914
Revenue 160M CAD (2024)
DESCRIPTION

Organigram is a producer of cannabis and cannabis-derived products in Canada and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused soft chews in Canada. Organigram was founded in 2010 and is based in Toronto, Ontario.

DEAL STATS #
Overall 4 of 4
Sector: Consumer Products M&A 3 of 3
Type: Add-on Acquisition M&A Deals 2 of 2
State: Ontario M&A 1 of 1
Country: Canada M&A 3 of 3
Year: 2024 M&A 2 of 2
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-06-25 Sanity Group

Berlin, Germany

Sanity Group improves people’s quality of life through the use of cannabinoids and the endocannabinoid system. In addition to pharmaceuticals, the focus is also on well-being and cosmetic products that utilize cannabinoids. The group comprises Vayamed and AVAAY Medical (medicinal cannabis), Endosane Pharmaceuticals (minority investment in finished pharmaceuticals), and VAAY (wellbeing). Sanity Group was formed in 2018 and is based in Berlin, Germany.

Buy -
Mergr

Solution for

Product

Company

Legal